A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK.A.O. Ellem, Richard C. Mulligan, Gregory R. Johnson et al.|Cancer Immunology Immunotherapy|1997Cited by 101